124 related articles for article (PubMed ID: 30125469)
1. Epidemiological Survey of Patients With Hemodialysis Complicated by Hepatitis C in Japan.
Okubo T; Atsukawa M; Tsubota A; Koeda M; Yoshida Y; Arai T; Nakagawa-Iwashita A; Itokawa N; Kondo C; Fujimori S; Tsuruoka S; Iwakiri K
Ther Apher Dial; 2019 Feb; 23(1):44-48. PubMed ID: 30125469
[TBL] [Abstract][Full Text] [Related]
2. Current elimination status of hepatitis C virus-infected maintenance hemodialysis patients in Iwate Prefecture, Japan.
Miyasaka A; Yoshida Y; Suzuki A; Endo K; Kakisaka K; Oikawa T; Abe T; Obara W; Matsumoto T
Ther Apher Dial; 2023 Oct; 27(5):848-854. PubMed ID: 37125473
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
Toyoda H; Kumada T; Tada T; Takaguchi K; Ishikawa T; Tsuji K; Zeniya M; Iio E; Tanaka Y
J Gastroenterol; 2016 Jul; 51(7):741-7. PubMed ID: 26872889
[TBL] [Abstract][Full Text] [Related]
4. The remaining challenges of HCV treatment in the direct-acting antivirals era.
Kim BK; Ahn SH
J Gastroenterol Hepatol; 2019 Nov; 34(11):1891-1892. PubMed ID: 31724229
[No Abstract] [Full Text] [Related]
5. Development of Interferon-Free, Direct-Acting Antivirals Treatment for Japanese Patients with Chronic Hepatitis C Infection and Chronic Kidney Disease.
Atsukawa M; Kondo C; Kawano T; Okubo T; Arai T; Nakagawa-Iwashita A; Itokawa N; Iwakiri K
J Nippon Med Sch; 2021 Jun; 88(3):163-170. PubMed ID: 33692289
[TBL] [Abstract][Full Text] [Related]
6. Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients.
Ohsawa M; Kato K; Itai K; Tanno K; Fujishima Y; Konda R; Okayama A; Abe K; Suzuki K; Nakamura M; Onoda T; Kawamura K; Sakata K; Akiba T; Fujioka T
J Epidemiol; 2010; 20(1):30-9. PubMed ID: 19881229
[TBL] [Abstract][Full Text] [Related]
7. Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis.
Miyazaki R; Miyagi K
Ther Apher Dial; 2016 Oct; 20(5):462-467. PubMed ID: 27098678
[TBL] [Abstract][Full Text] [Related]
8. Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.
Tabernilla A; Grandal M; Pernas B; Castro-Iglesias A; Rodríguez-Osorio I; Mena A; Delgado M; Cid P; Pedreira JD; Poveda E
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):781-785. PubMed ID: 28410351
[TBL] [Abstract][Full Text] [Related]
9. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F; Martin P; Messa P
Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
[TBL] [Abstract][Full Text] [Related]
10. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.
Mandour M; Nemr N; Shehata A; Kishk R; Badran D; Hawass N
Rev Soc Bras Med Trop; 2015; 48(3):258-64. PubMed ID: 26108002
[TBL] [Abstract][Full Text] [Related]
11. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
[TBL] [Abstract][Full Text] [Related]
12. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.
Kojima A; Kakizaki S; Hosonuma K; Yamazaki Y; Horiguchi N; Sato K; Kitahara T; Mori M
J Gastroenterol Hepatol; 2013 Apr; 28(4):690-9. PubMed ID: 23302054
[TBL] [Abstract][Full Text] [Related]
13. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
14. Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight.
Fabrizi F; Messa P; Martin P
Int J Artif Organs; 2009 Jan; 32(1):1-11. PubMed ID: 19241358
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of hepatitis C virus load during hemodialysis: novel perspectives.
Fabrizi F; Bunnapradist S; Lunghi G; Martin P
J Nephrol; 2003; 16(4):467-75. PubMed ID: 14696748
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.
Sagnelli E; Stroffolini T; Sagnelli C; Cacopardo B; Andriulli A; Babudieri S; Coppola N; Gaeta GB; Almasio PL
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):676-681. PubMed ID: 29465473
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of pegylated interferon alpha-2a in HCV-positive hemodialysis patients.
Ucmak H; Kokoglu OF; Hosoglu S; Dogan E; Sayarlioglu H; Kuzhan N; Isik IO
Ren Fail; 2008; 30(2):227-32. PubMed ID: 18300126
[TBL] [Abstract][Full Text] [Related]
19. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characterization of hepatitis C virus in hemodialysis patients.
Morikawa T; Nakata K; Hamasaki K; Tsuruta S; Kato Y; Nakao K; Ohtsubo T; Eguchi K
Intern Med; 1999 Aug; 38(8):626-31. PubMed ID: 10440497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
